Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | Healthcare | 1,245,254.0 | $44.2M | 6.14% | +430K | +52.8% | $35.52 | -3.7% |
| 2 | URGN | UROGEN PHARMA LTD | Healthcare | 1,738,821.0 | $40.7M | 5.66% | +162K | +10.2% | $23.42 | +26.7% |
| 3 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 2,427,118.0 | $39.2M | 5.44% | +1.1M | +78.0% | $16.15 | +65.7% |
| 4 | CELC | CELCUITY INC | Healthcare | 375,132.0 | $37.4M | 5.20% | +286K | +323.0% | $99.74 | +38.0% |
| 5 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 750,136.0 | $30.9M | 4.29% | +75K | +11.1% | $41.21 | +107.1% |
| 6 | KOD | KODIAK SCIENCES INC | Healthcare | 1,023,122.0 | $28.6M | 3.97% | +23K | +2.3% | $27.96 | +38.4% |
| 7 | — | PRAXIS PRECISION MEDICINES I | — | 82,465.0 | $24.3M | 3.38% | +31K | +61.0% | $294.74 | — |
| 8 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 1,029,066.0 | $16.1M | 2.24% | +334K | +48.1% | $15.68 | +19.1% |
| 9 | VCYT | VERACYTE INC | Healthcare | 357,558.0 | $15.1M | 2.09% | +122K | +51.6% | $42.10 | -7.6% |
| 10 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 642,899.0 | $13.5M | 1.88% | +179K | +38.6% | $21.01 | -2.2% |
| 11 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 458,203.0 | $11.5M | 1.59% | +317K | +224.4% | $25.01 | +58.3% |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 348,569.0 | $10.8M | 1.51% | +89K | +34.3% | $31.12 | -45.2% |
| 13 | — | BENITEC BIOPHARMA INC | — | 731,717.0 | $9.9M | 1.37% | +455K | +164.9% | $13.47 | — |
| 14 | CERS | CERUS CORP | Healthcare | 2,814,383.0 | $5.8M | 0.81% | +99K | +3.6% | $2.06 | +13.6% |
| 15 | CGEN | COMPUGEN LTD | Healthcare | 3,479,805.0 | $5.3M | 0.74% | +169K | +5.1% | $1.53 | +79.7% |
| 16 | CCCC | C4 THERAPEUTICS INC | Healthcare | 1,994,224.0 | $3.8M | 0.53% | +97K | +5.1% | $1.91 | +86.4% |
| 17 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 307,540.0 | $3.5M | 0.49% | +141K | +85.1% | $11.43 | +24.3% |
| 18 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 94,983.0 | $3.4M | 0.48% | +15K | +18.7% | $36.29 | -24.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%